For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
Passage Bio Inc (NASDAQ: PASG) closed the day trading at $0.43 down -11.38% from the previous closing price of $0.48. In other words, the price has decreased by -$11.38 from its previous closing price. On the day, 0.66 million shares were traded.
Ratios:
For a better understanding of PASG, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.15 and its Current Ratio is at 5.15. In the meantime, Its Debt-to-Equity ratio is 0.36 whereas as Long-Term Debt/Eq ratio is at 0.30.
On September 03, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $7.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 11 ’25 when Borthwick Kathleen sold 3,183 shares for $0.53 per share. The transaction valued at 1,686 led to the insider holds 41,283 shares of the business.
ORBIMED ADVISORS LLC sold 126,209 shares of PASG for $83,298 on Jan 10 ’25. The 10% Owner now owns 7,131,636 shares after completing the transaction at $0.66 per share. On Jan 14 ’25, another insider, ORBIMED ADVISORS LLC, who serves as the 10% Owner of the company, sold 79,024 shares for $0.60 each. As a result, the insider received 47,414 and left with 7,034,626 shares of the company.
Stock Price History:
Over the past 52 weeks, PASG has reached a high of $1.79, while it has fallen to a 52-week low of $0.45. The 50-Day Moving Average of the stock is -28.93%, while the 200-Day Moving Average is calculated to be -43.79%.
Shares Statistics:
A total of 61.77M shares are outstanding, with a floating share count of 51.91M. Insiders hold about 15.95% of the company’s shares, while institutions hold 44.91% stake in the company.
